Dincbas, F. O. Et Al. 2009. The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study. MEDICAL ONCOLOGY , vol.26, no.4 , 402-408.

Dincbas, F. O., Oksuz, D. C., Atalar, B., Altug, T., Ilvan, S., Gedik, N., ... Ozel, S.(2009). The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study. MEDICAL ONCOLOGY , vol.26, no.4, 402-408.

Dincbas, Hidayet Et Al. "The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study," MEDICAL ONCOLOGY , vol.26, no.4, 402-408, 2009

Dincbas, Hidayet F. Et Al. "The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study." MEDICAL ONCOLOGY , vol.26, no.4, pp.402-408, 2009

Dincbas, F. O. Et Al. (2009) . "The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study." MEDICAL ONCOLOGY , vol.26, no.4, pp.402-408.

@article{article, author={Hidayet Fazilet DİNÇBAŞ Et Al. }, title={The role of amifostine on late normal tissue damage induced by pelvic radiotherapy with concomitant gemcitabine: an in vivo study}, journal={MEDICAL ONCOLOGY}, year=2009, pages={402-408} }